Research and Markets: Companion Diagnostics Partnering Terms & Agreements Deals Analysis Report 2014

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/l7pgpp/companion) has announced the addition of the "Companion Diagnostics Partnering Terms & Agreements" report to their offering.

The Companion Diagnostics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the companion diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.

The report provides a detailed understanding and analysis of how and why companies enter companion diagnostic partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors companion diagnostics technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases do not.

The report also includes numerous tables and figures that illustrate the trends and activities in companion diagnostics partnering and dealmaking since 2009. The Appendix toward the end includes all the companion diagnostics deals since 2009 by company A-Z, deal type and therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Companion Diagnostics Partnering Terms and Agreements includes:

  • Trends in companion diagnostics dealmaking in the biopharma industry since 2009
  • Analysis of companion diagnostics deal structure
  • Access to headline, upfront, milestone and royalty data
  • Case studies of real-life companion diagnostics deals
  • Access to companion diagnostics contract documents
  • The leading companion diagnostics deals by value since 2009
  • Most active companion diagnostics dealmakers since 2009
  • The leading companion diagnostics partnering resources

In Companion Diagnostics Partnering Terms and Agreements, the available contracts are listed by:

  • Company A-Z
  • Headline value
  • Stage of development at signing
  • Deal component type
  • Specific therapy target

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in companion diagnostics dealmaking

Chapter 3 - Leading companion diagnostics deals

Chapter 4 - Big pharma companion diagnostics deals

Chapter 5 - Companion diagnostics contracts dealmaking directory

Chapter 6 - Companion diagnostics dealmaking by technology type

Chapter 7 - Companion diagnostics partnering resource center

For more information visit http://www.researchandmarkets.com/research/l7pgpp/companion

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices